Tucson, AZ5 Active Studies

Migraine Clinical Trials in Tucson, AZ

Find 5 actively recruiting migraine clinical trials in Tucson, AZ. Connect with local research sites and explore new treatment options.

5
Active Trials
2
Sponsors
3,708
Enrolling

Recruiting Migraine Studies in Tucson

RecruitingTucson, AZNCT04396236

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits....

1,633 participants
Eli Lilly and Company
View Study Details
RecruitingTucson, AZNCT04396574

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will la...

1,000 participants
Eli Lilly and Company
View Study Details
RecruitingTucson, AZNCT06417775

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, o...

450 participants
AbbVie
View Study Details
RecruitingTucson, AZNCT03432286

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary objective is t...

325 participants
Eli Lilly and Company
View Study Details
RecruitingTucson, AZNCT04616326

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is t...

300 participants
Eli Lilly and Company
View Study Details

About Migraine Clinical Trials in Tucson

Migraine is a neurological condition characterized by intense, debilitating headaches often accompanied by nausea, light sensitivity, and visual disturbances. It affects about 1 billion people globally and is a leading cause of disability. Treatments include preventive medications, acute therapies, and newer CGRP-targeting drugs.

There are currently 5 migraine clinical trials recruiting participants in Tucson, AZ. These studies are seeking a combined 3,708 participants. Research is being sponsored by Eli Lilly and Company, AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.

Migraine Clinical Trials in Tucson — FAQ

Are there migraine clinical trials in Tucson?

Yes, there are 5 migraine clinical trials currently recruiting in Tucson, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tucson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.

Are clinical trials in Tucson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.

What migraine treatments are being tested?

The 5 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for migraine.

Data updated March 2, 2026 from ClinicalTrials.gov